Development and validation of a LC-MS/MS method for assessment of an anti-inflammatory indolinone derivative by in vitro blood-brain barrier models

被引:8
|
作者
Jaehne, Evelyn A. [1 ]
Eigenmann, Daniela E. [1 ]
Culot, Maxime [2 ]
Cecchelli, Romeo [2 ]
Walter, Fruzsina R. [3 ]
Deli, Maria A. [3 ]
Tremmel, Robin [4 ]
Fricker, Gert [4 ]
Smiesko, Martin [5 ]
Hamburger, Matthias [1 ]
Oufir, Mouhssin [1 ]
机构
[1] Univ Basel, Dept Pharmaceut Sci, Inst Pharmaceut Biol, CH-4056 Basel, Switzerland
[2] Univ Lille Nord France, UArtois, BBB Lab EA 2465, IMPRT IFR114, F-62307 Lens, France
[3] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, H-6726 Szeged, Hungary
[4] Inst Pharm & Mol Biotechnol, D-69120 Heidelberg, Germany
[5] Univ Basel, Dept Pharmaceut Sci, CH-4056 Basel, Switzerland
基金
瑞士国家科学基金会;
关键词
Isatis tinctoria; (E,Z)-3-(4-Hydroxy-3,5-dimethoxybenzylidene)indolin-2-one; Anti-inflammatory; LC-MS/MS; Blood-brain barrier (BBB); TINCTORIA LEAF EXTRACTS; P-GLYCOPROTEIN EFFLUX; ISATIS-TINCTORIA; ENDOTHELIAL-CELLS; INHIBITORY-ACTIVITY; KINASE INHIBITORS; PURE TRYPTANTHRIN; DRUG DISCOVERY; PERMEABILITY; SYSTEM;
D O I
10.1016/j.jpba.2014.05.026
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The compound (E,Z)-3-(4-hydroxy-3,5-dimethoxybenzylidene)indolin-2-one (indolinone) was identified from lipophilic woad extracts (Isatis tinctoria L, Brassicaceae) as a compound possessing potent histamine release inhibitory and anti-inflammatory properties [1]. To further evaluate the potential of indolinone in terms of crossing the blood-brain barrier (BBB), we screened the compound in several in vitro cell-based human and animal BBB models. Therefore, we developed a quantitative LC-MS/MS method for the compound in modified Ringer HEPES buffer (RHB) and validated it according to FDA and EMA guidelines [2,3]. The calibration curve of indolinone in the range between 30.0 and 3000 ng/ml was quadratic, and the limit of quantification was 30.0 ng/ml. Dilution of samples up to 100-fold did not affect precision and accuracy. The carry-over was within acceptance criteria. Indolinone proved to be stable in RHB for 3 h at room temperature (RT), and for three successive freeze/thaw cycles. The processed samples could be stored in the autosampler at 10 degrees C for at least 28 h. Moreover, indolinone was stable for at least 16 days in RHB when stored below -65 degrees C. This validation study demonstrates that our method is specific, selective, precise, accurate, and capable to produce reliable results. In the immortalized human BBB mono-culture model, the apparent permeability coefficient from apical to basolateral (P-app A -> B), and the P-app from basolateral to apical (P-app (B -> A)) were 19.2 +/- 0.485 x 10(-6) cm/s and 21.7 +/- 0.326 x 10-6 cm/s, respectively. For the primary rat/bovine BBB co-culture model a P-app (A -> B) Of 27.1 +/- 1.67 x 10(-6) cm/s was determined. In the primary rat BBB triple co-culture model, the P-app A -> B and the P-app (B -> A) were 56.2 +/- 3.63 x 10(-6) cm/s and 34.6 +/- 1.41 x 10(-6) cm/s, respectively. The data obtained with the different models showed good correlation and were indicative of a high BBB permeation potential of indolinone confirmed by in silica prediction calculations. P-glycoprotein (P-gp) interaction for indolinone was studied with the aid of a calcein-AM uptake assay, and by calculation of the efflux ratio (ER) from the bidirectional permeability assays. For both bidirectional BBB models an ER below 2 was calculated, indicating that no active mediated transport mechanism is involved for indolinone. In porcine brain capillary endothelial cells (PBCECs), the calcein-AM uptake assay demonstrated that indolinone is neither a P-gp substrate nor a P-gp inhibitor and is accumulated into cells at high extent. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:235 / 246
页数:12
相关论文
共 50 条
  • [1] Development and validation of a LC-MS/MS method for assessment of an anti-inflammatory indolinone derivative by in vitro blood-brain barrier models
    Jaehne, E. A.
    PLANTA MEDICA, 2014, 80 (16) : 1375 - 1375
  • [2] Investigation of the metabolism of substance P at the blood-brain barrier using LC-MS/MS
    Chappa, Arvind K.
    Cooper, Joshua D.
    Audus, Kenneth L.
    Lunte, Susan M.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2007, 43 (04) : 1409 - 1415
  • [3] Method development and validation of cabozantinib by LC-MS/MS
    Venkateshwarlu, Punna
    Patel, Mehul M.
    PHARMACIA, 2022, 69 (02) : 407 - 413
  • [4] Development and validation of LC-MS/MS method for determining the metabolic stability, pharmacokinetics, and dose proportionality of a novel anti-inflammatory cofilin inhibitor
    Alsegiani, Amsha S.
    Shah, Zahoor A.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2023, 226
  • [5] LC-MS/MS-based in vitro and in vivo investigation of blood-brain barrier integrity by simultaneous quantitation of mannitol and sucrose
    Noorani, Behnam
    Chowdhury, Ekram Ahmed
    Alqahtani, Faleh
    Ahn, Yeseul
    Patel, Dhavalkumar
    Al-Ahmad, Abraham
    Mehvar, Reza
    Bickel, Ulrich
    FLUIDS AND BARRIERS OF THE CNS, 2020, 17 (01)
  • [6] Development and validation of a LC-MS/MS method for salicylate analysis
    Yang, Lufang
    Rawluk, Cathy
    Ball, Gordon
    Hoag, Gordon
    CLINICAL BIOCHEMISTRY, 2016, 49 (18)
  • [7] Method development and validation of tranexamic acid by LC-MS/MS
    Ivica, Josko
    Gauthier, Jeannette
    Lamy, Andre
    Potter, Murray
    CLINICAL BIOCHEMISTRY, 2019, 74 : 90 - 90
  • [8] Development and Validation of an LC-MS/MS Method and Comparison with a GC-MS Method to Measure Phenytoin in Human Brain Dialysate, Blood, and Saliva
    Hosli, Raphael
    Konig, Stefan
    Muhlebach, Stefan F.
    JOURNAL OF ANALYTICAL METHODS IN CHEMISTRY, 2018, 2018
  • [9] Development and validation of a highly sensitive LC-MS/MS method for in vitro measurement of histamine concentration
    Kim, Kwang-Youl
    Kwon, Hyun-Jung
    Cho, Sang-Heon
    Nam, Moonsuk
    Kim, Cheol-Woo
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2019, 172 : 33 - 41
  • [10] Evaluation of anti-inflammatory potential and LC-MS/MS analysis of different standards
    Sozmen, A. B.
    Canbay, E.
    Sozmen, E. Yildirim
    Ovez, B.
    FEBS OPEN BIO, 2018, 8 : 70 - 70